Equillium, Inc. (EQ) financial statements (2021 and earlier)

Company profile

Business Address 2223 AVENIDA DE LA PLAYA
LA JOLLA, CA 92037
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:825366
Cash and cash equivalents241329
Short-term investments584037
Other undisclosed cash, cash equivalents, and short-term investments0(0)(0)
Other undisclosed current assets321
Total current assets:855567
Noncurrent Assets
Property, plant and equipment000
Other noncurrent assets00 
Total noncurrent assets:000
TOTAL ASSETS:855667
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities642
Accounts payable321
Accrued liabilities321
Debt2  
Total current liabilities:742
Noncurrent Liabilities
Long-term debt and lease obligation810 
Long-term debt, excluding current maturities810 
Liabilities, other than long-term debt000
Other liabilities000
Total noncurrent liabilities:8100
Total liabilities:16142
Stockholders' equity
Stockholders' equity attributable to parent704265
Common stock000
Additional paid in capital1418380
Accumulated other comprehensive income (loss)(0)00
Accumulated deficit(71)(41)(16)
Total stockholders' equity:704265
TOTAL LIABILITIES AND EQUITY:855667

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Operating expenses(30)(27)(9)
Operating loss:(30)(27)(9)
Nonoperating income (expense)(0)1(5)
Investment income, nonoperating010
Other nonoperating income00 
Interest and debt expense(1)(0)(3)
Other undisclosed income from continuing operations before equity method investments, income taxes10 
Loss before gain (loss) on sale of properties:(30)(26)(16)
Other undisclosed net income  3
Net loss available to common stockholders, diluted:(30)(26)(13)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(30)(26)(13)
Other comprehensive income (loss)(0)0 
Comprehensive loss:(30)(26)(13)
Other undisclosed comprehensive income, net of tax, attributable to parent  0
Comprehensive loss, net of tax, attributable to parent:(30)(26)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: